NCT03869333View on ClinicalTrials.gov

Dose Escalating Study of Intramuscular Invaplex[AR-DETOX]

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 18, 2019

Primary Completion Date

June 12, 2020

Study Completion Date

June 12, 2020

Conditions
Diarrhea
Interventions
BIOLOGICAL

Invaplex[AR-DETOX]

Detoxified Shigella flexneri 2a Artificial Invasin Complex (Invaplex\[AR-Detox\]) Vaccine

OTHER

Placebo

Saline

Trial Locations (1)

20910

Walter Reed Army Institute of Research Clinical Trials Center (WRAIR CTC), Silver Spring

All Listed Sponsors
lead

PATH

OTHER

NCT03869333 - Dose Escalating Study of Intramuscular Invaplex[AR-DETOX] | Biotech Hunter | Biotech Hunter